While T-cell studies in cancer have mainly focused on CD8 T cells, given their direct tumoricidal activities and the lack of MHC class II expression in many cancer types, recent data argue for a crucial contribution of CD4 T cells to tumour immunity (62). The gene discussed is CD8A; the disease is cancer.